Altria Group, Inc. (MO) KPIs and segments
Close on Nov 17, 2026Market cap $128.85BP/E 16.0Yield 5.37%
KPI & bộ phận
Chỉ số vận hành và bộ phận làm nên hoạt động của Altria · năm tài chính kết thúc ngày 31 tháng 12
Nhìn nhanh KPI của Altria: 28 chỉ số vận hành, trong đó có Total Domestic Smokeable Products Shipment Volume, PM USA Total Domestic Cigarettes Retail Share và Marlboro Average Retail Price, lấy từ 220 tài liệu nguồn, cùng doanh thu theo bộ phận, sản phẩm và khu vực từ hồ sơ SEC. Mỗi số đều dẫn tới tài liệu gốc. Tất cả chỉ số hiện cả bảng; Cốt lõi chỉ giữ bộ phận và KPI nổi bật. Bảng bộ phận còn có cách xem lũy kế 12 tháng.
Biểu đồ đang trống. Tick vào ô cạnh bất kỳ chỉ số nào ở bảng dưới để vẽ — tick nhiều chỉ số để so sánh trên cùng một biểu đồ.
Bộ phận, KPI nổi bật và mọi chỉ số vận hành từ hồ sơ, thông cáo kết quả và bản trình bày.
| Thêm vào biểu đồ | Chỉ số | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Smokeable Products Segment($M) | 5,432 | 5,392 | 4,758 | 5,119 | 5,387 | 5,357 | 4,622 | 5,263 | 5,540 | 5,495 | 4,906 | 5,274 | |
Oral Tobacco Segment($M) | 688 | 713 | 669 | 706 | 689 | 753 | 654 | 692 | 722 | 711 | 651 | 674 | |
Other($M) | 12 | 6 | 1 | 34 | -4 | -8 | -17 | 19 | -3 | 3 | 19 | 27 | |
Smokeable Products Segment($M) | 3,053 | 2,942 | 2,673 | 2,643 | 2,942 | 2,930 | 2,469 | 2,638 | 2,937 | 2,807 | 2,439 | 2,578 | |
Oral Tobacco Segment($M) | 434 | 381 | 435 | 438 | 459 | 498 | 433 | 453 | 464 | 97 | 435 | 408 | |
Other($M) | -88 | -77 | -76 | 969 | -76 | -108 | -1,014 | ||||||
Oral Tobacco Segment($M) | -44 | -18 | -34 | -33 | -20 | -9 | -13 | -15 | -8 | -7 | -9 | ||
Smokeable Products Segment($M) | -56 | -29 | -52 | -50 | -27 | -12 | -18 | -16 | -11 | -9 | -18 | ||
Total Domestic Smokeable Products Shipment Volume (million sticks)(M)4 | 16,182 | 16,057 | 14,271 | 15,739 | 16,645 | 16,545 | 14,609 | 17,024 | 18,085 | 18,360 | 16,867 | 18,623 | |
Total Domestic Cigarettes Shipment Volume (million sticks)(M)5 | 15,725 | 15,554 | 13,867 | 15,290 | 16,192 | 16,066 | 14,204 | 16,593 | 17,641 | 17,898 | 16,450 | 18,204 | |
Marlboro Cigarette Shipment Volume (million sticks)(M) | 13,324 | 13,389 | 11,960 | 13,262 | 14,235 | 14,458 | 12,978 | 15,173 | 16,122 | 16,316 | 14,973 | 16,462 | |
Other Premium Cigarettes Shipment Volume (Parliament, Virginia Slims — million sticks)(M) | 697 | 678 | 601 | 704 | 744 | 719 | 678 | 789 | 824 | 826 | 747 | 859 | |
Discount Cigarettes Shipment Volume (Basic, L&M — million sticks)(M) | 1,704 | 1,487 | 1,306 | 1,324 | 1,213 | 889 | 548 | 631 | 695 | 756 | 730 | 883 | |
Adjusted Domestic Cigarette Shipment Volume Change YoY (adjusted for trade inventory & calendar, %)(%) | -4.0% | -4.0% | -4.0% | -7.0% | -9.0% | -11.0% | -12.0% | -11.5% | -10.5% | -9.0% | |||
Estimated Total Domestic Cigarette Industry Volume Change YoY (%)(%) | -5.0% | -5.0% | -5.0% | ||||||||||
Total Domestic Cigars Shipment Volume — John Middleton (million sticks)(M)2 | 457 | 503 | 404 | 449 | 453 | 479 | 405 | 431 | 444 | 462 | 417 | 419 | |
Black & Mild Cigars Shipment Volume (million sticks)(M) | 456 | 503 | 403 | 448 | 452 | 478 | 405 | 430 | 443 | 460 | 417 | 418 | |
Other Cigars Shipment Volume (million sticks)(M) | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 2 | 0 | 1 | |
Contract Manufactured Export Cigarettes Shipment Volume (million sticks)(M) | 1,595 | 736 | 610 | 311 | 475 | 0 | |||||||
Smokeable Products Shipping Days in Period (days)(ngày) | 66 | 65 | 64 | 66 | 66 | 65 | 64 | 66 | 66 | 65 | 65 | 65 | |
PM USA Total Domestic Cigarettes Retail Share (Circana / IRI, %)(%)5 | 45.7% | 45.5% | 45.4% | 45.2% | 45.4% | 45.2% | 45.0% | 45.4% | 45.7% | 46.2% | 46.4% | 46.8% | |
Marlboro Retail Share of Total Cigarette Category (%)(%)1 | 39.5% | 39.5% | 39.7% | 39.8% | 40.5% | 41.0% | 41.1% | 41.3% | 41.6% | 41.9% | 42.0% | 42.3% | |
Marlboro Retail Share of the Premium Cigarette Segment (%)(%) | 60.0% | 59.6% | 59.5% | 59.2% | 59.6% | 59.4% | 59.3% | 59.4% | 59.3% | 59.3% | 59.3% | 59.2% | |
Other Premium Brands Retail Share of Cigarette Category (%)(%) | 2.1% | 2.1% | 2.1% | 2.2% | 2.2% | 2.2% | 2.2% | 2.2% | 2.2% | 2.3% | 2.3% | 2.3% | |
PM USA Discount Brands (Basic, L&M) Retail Share of Cigarette Category (%)(%) | 4.1% | 3.9% | 3.6% | 3.2% | 2.7% | 2.0% | 1.7% | 1.9% | 1.9% | 2.0% | 2.1% | 2.2% | |
PM USA Menthol Retail Share of Cigarette Category (%)(%) | 8.1% | 7.9% | 7.9% | 7.9% | 8.0% | 7.9% | 7.9% | 8.0% | 8.0% | 8.1% | 8.1% | 8.4% | |
Total U.S. Cigarette Industry Discount Segment Retail Share (%)(%)2 | 34.1% | 33.8% | 33.3% | 32.9% | 32.2% | 31.2% | 30.9% | 30.4% | 29.8% | 29.3% | 29.1% | 28.6% | |
Major Manufacturer Discount Retail Share (PM USA, Reynolds, ITG — %)(%) | 18.1% | 17.8% | 17.4% | 17.3% | 16.7% | 15.9% | 15.5% | 15.5% | 15.4% | 15.3% | 15.3% | 15.2% | |
All Other Manufacturer / Deep Discount Retail Share (%)(%) | 16.0% | 16.0% | 15.9% | 15.6% | 15.5% | 15.3% | 15.4% | 14.9% | 14.4% | 14.0% | 13.8% | 13.4% | |
Marlboro Average Retail Price ($/pack)($)4 | 10 | 10 | 10 | 10 | 10 | 10 | 9 | 10 | 9 | 9 | 9 | 9 | |
Estimated Weighted Average State Excise Tax ($/pack)($) | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |
Lowest Effective Cigarette Retail Price ($/pack, through Q4 2024)($) | 6 | 6 | 6 | 6 | 6 | ||||||||
Marlboro Price Gap vs. Lowest Effective Cigarette Price (%, through Q4 2024)(%) | 49.0% | 47.0% | 46.0% | 46.0% | 44.0% | ||||||||
U.S. Cigarette Industry Wholesale Inventory Estimates (billion units)(M)1 | 8.80 | 6.60 | 7 | 6.90 | 7.60 | 6.30 | 6.80 | 7.40 | 7.60 | 6 | 5.90 | 7.80 | |
PM USA Cigarette Wholesale Inventory Estimates (billion units)(M) | 2.60 | 2.60 | 2.50 | 2.50 | 2.40 | 2.50 | 2.30 | 2.50 | 2.20 | 2.20 | 2.10 | 2.40 | |
LTM Domestic Cigarette Industry Volume Decline Estimate (12-Month Rolling, %)(%)3 | -5.5% | -6.0% | -7.0% | -8.0% | -8.5% | -8.5% | -9.0% | -9.0% | -9.0% | -8.5% | -8.0% | -8.0% | |
Cigarette Industry Secular Decline Rate (LTM, %)(%) | -2.5% | -2.5% | -2.5% | -2.5% | -2.5% | -2.5% | -2.5% | -2.5% | -2.5% | -2.5% | -2.5% | -2.5% | |
Cigarette Price Elasticity Impact on Industry Volume (LTM, %)(%) | -1.7% | -1.9% | -2.0% | -2.1% | -2.1% | -2.1% | -2.0% | -2.1% | -2.0% | -1.9% | -1.8% | -1.9% | |
Macroeconomic, Cross-Category Movement & Other Factors Impact (LTM, %)(%) | -1.3% | -1.6% | -2.5% | -3.4% | -3.9% | -3.9% | -4.5% | -4.4% | -4.5% | -4.1% | -3.7% | -3.6% | |
Total Domestic Oral Tobacco Products Shipment Volume (million cans and packs)(M)5 | 171 | 182 | 170 | 180 | 178 | 199 | 175 | 192 | 197 | 201 | 185 | 193 | |
Copenhagen Moist Smokeless Tobacco Shipment Volume (million cans)(M) | 79.8 | 85.4 | 80.4 | 88.4 | 88.8 | 95.9 | 89.7 | 97.1 | 101 | 104 | 99.1 | 107 | |
on! Oral Nicotine Pouches Shipment Volume — Helix Innovations (million cans)(M) | 47.8 | 49.9 | 46.2 | 44.2 | 42.2 | 52.1 | 39.3 | 43.9 | 41.9 | 41.2 | 33.3 | 30.4 | |
Skoal Moist Smokeless Tobacco Shipment Volume (million cans)(M) | 27.1 | 29.5 | 27.9 | 31.3 | 31 | 34.2 | 31.4 | 35.4 | 37.4 | 37.5 | 36.7 | 39.8 | |
Other Oral Tobacco (Red Seal, Husky) Shipment Volume (million cans)(M) | 15.9 | 16.9 | 15.4 | 16.3 | 16.2 | 16.4 | 15 | 15.9 | 16.4 | 18.1 | 15.5 | 16.1 | |
Adjusted Domestic Oral Tobacco Shipment Volume Change YoY (%)(%) | -5.0% | -5.5% | -8.5% | -6.0% | -5.5% | -2.5% | -1.0% | -1.0% | -3.5% | -4.0% | -2.5% | ||
Total U.S. Oral Tobacco Category Retail Share — USSTC & Helix (Circana / IRI, %)(%)4 | 27.9% | 29.0% | 29.0% | 29.6% | 30.6% | 32.7% | 34.5% | 36.1% | 37.2% | 37.7% | 37.8% | 39.9% | |
Copenhagen Retail Share of U.S. Oral Tobacco Category (%)(%) | 12.6% | 13.1% | 13.7% | 14.2% | 14.6% | 15.9% | 16.9% | 17.8% | 18.5% | 19.4% | 20.1% | 21.7% | |
on! Nicotine Pouches Retail Share of U.S. Oral Tobacco Category (%)(%)2 | 8.3% | 8.6% | 7.8% | 7.7% | 8.2% | 8.3% | 8.6% | 8.7% | 8.8% | 8.0% | 7.0% | 6.9% | |
U.S. Nicotine Pouch Category Share of Total Oral Tobacco Category (%)(%) | 61.2% | 59.0% | 58.1% | 56.9% | 55.7% | 50.6% | 49.1% | 45.7% | 43.9% | 40.9% | 40.1% | 35.9% | |
on! Retail Share within the U.S. Nicotine Pouch Category (%)(%) | 13.5% | 13.9% | 13.4% | 13.4% | 15.6% | 17.3% | 17.9% | 19.2% | 19.1% | 18.5% | 17.6% | 22.0% | |
Skoal Retail Share of U.S. Oral Tobacco Category (%)(%) | 4.8% | 5.1% | 5.3% | 5.5% | 5.5% | 6.1% | 6.5% | 7.0% | 7.3% | 7.7% | 8.0% | 8.6% | |
Other Oral Brands (Red Seal, Husky) Retail Share of U.S. Oral Tobacco Category (%)(%) | 2.2% | 2.2% | 2.2% | 2.2% | 2.3% | 2.4% | 2.5% | 2.6% | 2.6% | 2.6% | 2.7% | 2.7% | |
Copenhagen Average Retail Price ($/can)($)1 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | |
on! Nicotine Pouches Average Retail Price ($/can)($) | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 4 | |
Total U.S. Smoke-Free Product Volume (Oral + E-Vapor, million units, FY2022–FY2024)1 | |||||||||||||
NJOY E-Vapor Consumables Shipment Volume (million units, through Q1 2025 prior to ITC exclusion order)(M)2 | 13.5 | 12.8 | 10.4 | 12.5 | |||||||||
NJOY E-Vapor Devices Shipment Volume (million units, through Q1 2025)(M) | 0.30 | 1.10 | 1.10 | 1.80 | |||||||||
NJOY Retail Share of U.S. Multi-Outlet & Convenience E-Vapor Consumables (%, through Q1 2025)(%) | 6.6% | 6.4% | 6.2% | ||||||||||
Smokeable Products — Revenues Net of Excise Taxes ($M)($M)2 | 4,762 | 4,660 | 4,110 | 4,376 | 4,590 | 4,570 | 3,907 | 4,424 | 4,652 | 4,587 | 4,072 | 4,350 | |
Smokeable Products — Excise Taxes on Products Sold ($M)($M) | 670 | 732 | 648 | 743 | 797 | 787 | 715 | 839 | 888 | 908 | 834 | 924 | |
Smokeable Products — Adjusted Operating Companies Income (Adjusted OCI, $M)($M)5 | 3,072 | 3,018 | 2,676 | 2,643 | 2,956 | 2,947 | 2,518 | 2,709 | 2,935 | 2,827 | 2,451 | 2,568 | |
Smokeable Products — Adjusted OCI Margin (% of Revenues Net of Excise Taxes)(%) | 64.5% | 64.8% | 65.1% | 60.4% | 64.4% | 64.5% | 64.4% | 61.2% | 63.1% | 61.6% | 60.2% | 59.0% | |
Smokeable Products — Reported OCI Margin (% of Revenues Net of Excise Taxes)(%) | 64.1% | 63.1% | 65.0% | 60.4% | 64.1% | 64.1% | 63.2% | 59.6% | 63.1% | 61.2% | 59.9% | 59.3% | |
Smokeable Products — NPM Adjustment Items ($M)($M) | 0 | 0 | -4 | -22 | -2 | 0 | 0 | 0 | -23 | 0 | -6 | -14 | |
Smokeable Products — Asset Impairment, Exit & Implementation Costs ($M)($M) | 3 | 9 | 5 | 11 | 12 | 13 | 13 | 60 | 0 | 0 | 0 | 0 | |
Smokeable Products — Tobacco & Health Litigation Items ($M)($M) | 16 | 67 | 2 | 11 | 4 | 4 | 36 | 11 | 21 | 20 | 18 | 4 | |
Oral Tobacco Products — Revenues Net of Excise Taxes ($M)($M)2 | 667 | 690 | 647 | 682 | 665 | 728 | 629 | 663 | 695 | 687 | 626 | 647 | |
Oral Tobacco Products — Excise Taxes on Products Sold ($M)($M) | 21 | 23 | 22 | 24 | 24 | 25 | 25 | 29 | 27 | 24 | 25 | 27 | |
Oral Tobacco Products — Adjusted Operating Companies Income (Adjusted OCI, $M)($M)2 | 443 | 460 | 436 | 440 | 460 | 500 | 435 | 461 | 464 | 451 | 435 | 408 | |
Oral Tobacco Products — Adjusted OCI Margin (% of Revenues Net of Excise Taxes)(%) | 66.4% | 66.7% | 67.4% | 64.5% | 69.2% | 68.7% | 69.2% | 69.5% | 66.8% | 65.6% | 69.5% | 63.1% | |
Oral Tobacco Products — Reported OCI Margin (% of Revenues Net of Excise Taxes)(%) | 65.1% | 55.2% | 67.2% | 64.2% | 69.0% | 68.4% | 68.8% | 68.3% | 66.8% | 14.1% | 69.5% | 63.1% | |
State Settlement Agreements (MSA) Charges Included in Cost of Sales — Total ($M)($M)4 | 775 | 785 | 668 | 750 | 792 | 799 | 687 | 806 | 878 | 926 | 858 | 880 | |
State Settlement Agreements (MSA) Charges — Smokeable Products ($M)($M) | 775 | 785 | 668 | 750 | 792 | 799 | 687 | 806 | 875 | 924 | 855 | 879 | |
State Settlement Agreements (MSA) Charges — Oral Tobacco Products ($M)($M) | 0 | 0 | 0 | 0 | 0 | 3 | 2 | 3 | 1 | ||||
FDA User Fees Included in Cost of Sales — Total ($M)($M)2 | 61 | 65 | 65 | 62 | 66 | 59 | 63 | 60 | 68 | 65 | 61 | 67 | |
FDA User Fees — Smokeable Products ($M)($M) | 60 | 63 | 64 | 61 | 64 | 58 | 62 | 59 | 66 | 64 | 60 | 66 | |
FDA User Fees — Oral Tobacco Products ($M)($M) | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | |
Consolidated Excise Taxes on Products Sold — Total ($M)($M) | 691 | 755 | 670 | 767 | 821 | 812 | 740 | 868 | 915 | 932 | 859 | 951 | |
Total Inventories on Balance Sheet ($M)($M)7 | 1,084 | 1,060 | 1,146 | 1,070 | 1,065 | 1,016 | 1,062 | 1,080 | 1,101 | 1,174 | 1,241 | 1,215 | |
Leaf Tobacco Inventory ($M)($M) | 400 | 420 | 525 | 531 | 502 | 475 | 531 | 591 | 524 | 562 | 610 | 649 | |
Finished Product Inventory ($M)($M) | 379 | 345 | 332 | 281 | 336 | 320 | 310 | 278 | 362 | 388 | 405 | 340 | |
Other Raw Materials Inventory ($M)($M) | 288 | 277 | 265 | 245 | 208 | 200 | 195 | 190 | 189 | 199 | 199 | 204 | |
Work in Process Inventory ($M)($M) | 17 | 18 | 24 | 13 | 19 | 21 | 26 | 21 | 26 | 25 | 27 | 22 | |
Accrued Settlement Charges (MSA Current Liability, $M)($M) | 1,942 | 1,169 | 2,837 | 2,178 | 1,887 | 1,098 | 3,032 | 2,354 | 2,118 | 1,320 | 3,420 | 2,563 | |
Accrued Marketing Liabilities ($M)($M) | 980 | 1,089 | 895 | 928 | 886 | 894 | 758 | 688 | 817 | 763 | 720 | 716 | |
Dividends Payable ($M)($M) | 1,857 | 1,777 | 1,779 | 1,782 | 1,787 | 1,723 | 1,727 | 1,732 | 1,739 | 1,690 | 1,690 | 1,735 | |
Total Capital Expenditures by Segment ($M)($M)4 | 109 | 57 | 93 | 92 | 54 | 32 | 38 | 47 | 31 | 29 | 35 | 53 | |
Capital Expenditures — Smokeable Products ($M)($M) | 56 | 29 | 52 | 50 | 27 | 12 | 18 | 16 | 11 | 9 | 18 | ||
Capital Expenditures — Oral Tobacco Products ($M)($M) | 44 | 18 | 34 | 33 | 20 | 9 | 13 | 15 | 8 | 7 | 9 | ||
Capital Expenditures — General Corporate & Other ($M)($M) | 9 | 10 | 7 | 8 | 7 | 11 | 7 | 16 | 12 | 13 | 8 | ||
Total Depreciation Expense by Segment ($M)($M)4 | 39 | 33 | 33 | 34 | 32 | 34 | 34 | 36 | 36 | 37 | 38 | ||
Depreciation Expense — Smokeable Products ($M)($M) | 16 | 14 | 13 | 14 | 15 | 14 | 15 | 15 | 16 | 17 | 19 | ||
Depreciation Expense — Oral Tobacco Products ($M)($M) | 14 | 11 | 11 | 11 | 9 | 11 | 10 | 12 | 9 | 12 | 9 | ||
Depreciation Expense — General Corporate & Other ($M)($M) | 9 | 8 | 9 | 9 | 8 | 9 | 9 | 6 | 11 | 8 | 10 | ||
Ongoing Total Depreciation and Amortization (Quarterly Metrics, $M)($M) | 60 | 56 | 56 | 54 | 70 | 71 | 71 | 73 | 74 | 74 | 65 | 78 | |
Adjusted Diluted Earnings Per Share ($/share)($)5 | 2 | 1 | 1 | 5 | 1 | 1 | 1 | 5 | 1 | 1 | 1 | 1 | |
Reported Diluted Earnings Per Share ($/share)($) | 2 | 1 | 1 | 4 | 1 | 1 | 1 | 7 | 1 | 2 | 1 | 1 | |
Full-Year Adjusted Diluted EPS Guidance — Low End ($/share)($) | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||
Full-Year Adjusted Diluted EPS Guidance — High End ($/share)($) | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||
Adjusted Effective Income Tax Rate (%)(%) | 23.0% | 23.0% | 23.1% | 24.1% | 23.9% | 24.3% | 24.8% | 24.6% | |||||
Reported Effective Income Tax Rate (%)(%) | 23.6% | 21.5% | 23.6% | 26.2% | 22.8% | 23.7% | 36.0% | -9.4% | 24.2% | 25.7% | 22.3% | 24.7% | |
Altria Investment in AB InBev — Carrying Value on Balance Sheet ($M)($M)3 | 9,003 | 8,577 | 8,627 | 8,303 | 8,071 | 7,837 | 7,798 | 7,880 | 7,846 | 8,020 | 8,070 | 9,676 | |
Altria Investment in AB InBev — Fair Value ($B)(M) | 11.8 | 13.2 | 11 | 10.3 | 9.50 | 10.9 | 9.80 | 12.7 | |||||
Altria Ownership Interest in AB InBev (%)(%) | 8.1% | 8.1% | 8.2% | 8.2% | 8.1% | 8.1% | 8.1% | 8.1% | 8.1% | 8.1% | 8.1% | 10.0% | |
Altria Share of AB InBev Equity Method Net Income ($M)($M) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
AB InBev (NYSE: BUD) — Worldwide Total Beverage Volume (thousand hectoliters)9 | 142,313 | 144,003 | 136,409 | 139,166 | 142,319 | 143,347 | 136,268 | 141,829 | 148,039 | 146,302 | 139,536 | 144,706 | |
AB InBev — Worldwide Beer Volume (thousand hectoliters) | 124,370 | 126,945 | 118,480 | 119,039 | 124,692 | 125,620 | 117,385 | 121,052 | 128,534 | 127,242 | 119,683 | ||
AB InBev — Worldwide Non-Beer Volume (thousand hectoliters) | 17,943 | 17,058 | 17,929 | 20,127 | 17,627 | 17,727 | 18,883 | 20,777 | 19,505 | 19,059 | 19,852 | ||
AB InBev — North America Beverage Volume (thousand hectoliters) | 21,520 | 22,430 | 19,131 | 18,619 | 21,896 | 22,376 | 19,842 | 19,516 | 22,764 | 22,639 | 21,353 | 19,738 | |
AB InBev — Middle Americas Beverage Volume (thousand hectoliters) | 38,967 | 39,994 | 35,985 | 39,672 | 36,915 | 38,822 | 35,081 | 38,907 | 37,107 | 38,381 | 35,690 | 38,635 | |
AB InBev — South America Beverage Volume (thousand hectoliters) | 37,213 | 34,665 | 40,765 | 43,160 | 36,922 | 34,199 | 40,891 | 44,950 | 39,502 | 35,969 | 40,347 | 46,704 | |
AB InBev — EMEA Beverage Volume (thousand hectoliters) | 24,680 | 24,239 | 20,931 | 24,249 | 24,149 | 24,172 | 20,752 | 24,883 | 24,039 | 23,852 | 21,030 | 23,964 | |
AB InBev — Asia Pacific Beverage Volume (thousand hectoliters) | 19,821 | 22,586 | 19,548 | 13,334 | 22,301 | 23,716 | 19,648 | 13,439 | 24,514 | 25,399 | 21,045 | 15,465 | |
AB InBev — Consolidated Revenue ($M)($M) | 16,512 | 16,660 | 15,267 | 15,555 | 15,133 | 15,004 | 13,628 | 14,841 | 15,046 | 15,333 | 14,547 | 14,473 | |
AB InBev — Normalized EBITDA ($M)($M) | 5,957 | 5,938 | 5,437 | 5,473 | 5,594 | 5,301 | 4,855 | 5,245 | 5,424 | 5,302 | 4,987 | 4,877 | |
Altria Investment in Cronos Group — Carrying Value on Balance Sheet ($M)($M)3 | 323 | 319 | 320 | 314 | 314 | 306 | 307 | 315 | 307 | 315 | 326 | 335 | |
Altria Investment in Cronos Group — Fair Value ($M)($M) | 517 | 432 | 396 | 411 | |||||||||
Altria Ownership Interest in Cronos Group (%)(%) | 42.6% | 42.2% | 41.6% | 41.0% | 40.9% | 40.8% | 40.6% | 40.9% | 41.0% | ||||
Total Equity Method Investments Carrying Value on Altria Balance Sheet (ABI + Cronos, $M)($M) | 9,326 | 8,896 | 8,947 | 8,617 | 8,385 | 8,143 | 8,105 | 8,195 | 8,153 | 8,335 | 8,396 | 10,011 | |
Cronos Group Inc. (NASDAQ: CRON) — Consolidated Net Revenue After Excise Taxes ($K, through Q2 2026)6 | 53,007 | 45,210 | 44,531 | 36,339 | 33,455 | 32,262 | 30,301 | 34,264 | 25,288 | 23,915 | |||
Cronos Group — Gross Revenue Before Excise Taxes ($K) | 70,597 | 58,965 | 58,385 | 48,828 | 44,252 | 41,898 | 41,182 | 46,594 | 35,367 | 34,006 | |||
Cronos Group — Cannabis Flower Net Revenue ($K) | 39,214 | 33,734 | 33,745 | 26,362 | 25,025 | 23,344 | 23,398 | 26,328 | 20,661 | 17,525 | -23,992 | ||
Cronos Group — Cannabis Extracts Net Revenue ($K) | 13,774 | 11,457 | 10,768 | 9,964 | 8,360 | 8,608 | 6,588 | 7,789 | 7,064 | 7,727 | -9,963 | ||
Cronos Group — Canada Net Revenue ($K) | 28,710 | 25,351 | 27,918 | 23,132 | 19,150 | 20,130 | 19,656 | 24,067 | 19,844 | 18,871 | -38,874 | ||
Cronos Group — Israel Medical Cannabis Net Revenue ($K) | 15,018 | 14,151 | 11,838 | 11,353 | 9,376 | 9,229 | 7,803 | 7,259 | 6,889 | 6,417 | -2,732 | ||
Cronos Group — Consolidated Gross Profit ($K) | 28,451 | 19,153 | 16,189 | 18,332 | 14,504 | 13,734 | 10,807 | 3,611 | 4,483 | 1,913 | |||
Competitor Benchmark: PMI Americas Nicotine Pouches (ZYN) Shipment Volume (million cans, FY2023Q1–FY2025Q4)(M)3 | 198 | 206 | 191 | 202 | 165 | 150 | 135 | 132 | 116 | ||||
PMI Worldwide Nicotine Pouches (ZYN) Shipment Volume (million cans)(M) | 217 | 225 | 215 | 223 | 184 | 165 | 150 | 146 | 126 | ||||
PMI Americas Moist Snuff Shipment Volume (million cans)(M) | 31.2 | 31.6 | 33.4 | 33.6 | 32 | 34.1 | 34.2 | 34.4 | 31.2 | ||||
PMI Americas Total Oral Smoke-Free Shipment Volume (million cans)(M) | 230 | 238 | 225 | 237 | 198 | 184 | 170 | 167 | 148 | ||||
Consolidated Net Revenues ($M)($M)10 | 6,132 | 6,111 | 5,428 | 5,846 | 6,072 | 6,102 | 5,259 | 5,974 | 6,259 | 6,209 | 5,576 | 5,975 | |
Cost of Sales ($M)($M) | 1,500 | 1,536 | 1,252 | 1,448 | 1,439 | 1,440 | 1,270 | 1,502 | 1,536 | 1,602 | 1,437 | 1,525 | |
Gross Profit ($M)($M) | 3,941 | 3,820 | 3,506 | 3,631 | 3,812 | 3,850 | 3,249 | 3,604 | 3,808 | 3,675 | 3,280 | 3,499 | |
Operating Income ($M)($M) | 3,313 | 3,136 | 2,956 | 1,651 | 3,230 | 3,230 | 1,788 | 2,882 | 3,152 | 2,533 | 2,674 | 2,796 | |
Equity Method Investment Income ($M)($M) | 242 | 87 | 158 | 112 | 107 | 148 | 143 | 122 | 116 | 119 | 295 | 138 | |
Earnings Before Income Taxes ($M)($M) | 3,290 | 2,929 | 2,859 | 1,513 | 3,075 | 3,118 | 1,683 | 2,777 | 3,026 | 5,116 | 2,739 | 2,735 | |
Provision for Income Taxes ($M)($M) | 776 | 631 | 676 | 396 | 700 | 740 | 606 | -262 | 733 | 1,313 | 610 | 675 | |
Net Earnings Attributable to Altria ($M)($M) | 2,518 | 2,298 | 2,183 | 1,117 | 2,375 | 2,378 | 1,077 | 3,039 | 2,293 | 3,803 | 2,129 | 2,060 | |
Reported Diluted EPS ($/share)($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Weighted-Average Diluted Shares (M)(M) | 1,669 | 1,670 | 1,673 | 1,680 | 1,684 | 1,690 | 1,703 | 1,718 | 1,758 | ||||
Dividends Declared per Share ($/share)($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Assets ($M)($M)9 | 34,478 | 33,374 | 34,584 | 35,017 | 35,008 | 32,332 | 35,760 | 35,177 | 34,167 | 34,387 | 36,475 | 38,570 | |
Cash and Cash Equivalents ($M)($M) | 2,697 | 2,367 | 3,531 | 4,474 | 3,496 | 1,311 | 4,750 | 3,158 | 1,928 | 1,836 | 3,646 | 3,686 | |
Receivables ($M)($M) | 342 | 306 | 284 | 263 | 249 | 241 | 258 | 177 | 87 | 72 | 77 | 71 | |
Total Inventories ($M)($M) | 1,084 | 1,060 | 1,146 | 1,070 | 1,065 | 1,016 | 1,062 | 1,080 | 1,101 | 1,174 | 1,241 | 1,215 | |
Property, Plant and Equipment, Net ($M)($M) | 1,669 | 1,757 | 1,730 | 1,710 | 1,617 | 1,610 | 1,608 | 1,617 | 1,618 | 1,620 | 1,624 | 1,652 | |
Goodwill ($M)($M) | 5,787 | 5,787 | 5,787 | 5,787 | 6,072 | 6,072 | 6,072 | 6,945 | 6,945 | 6,945 | 6,945 | 6,791 | |
Other Intangible Assets, Net ($M)($M) | 11,829 | 11,850 | 11,873 | 11,876 | 12,866 | 12,900 | 12,936 | 12,973 | 13,010 | 3,600 | 13,439 | 13,686 | |
Total Liabilities ($M)($M) | 36,651 | 35,992 | 37,745 | 38,469 | 37,604 | 35,538 | 39,220 | 37,365 | 37,585 | 37,353 | 41,539 | 42,060 | |
Long-Term Debt ($M)($M) | 22,886 | 22,893 | 24,060 | 24,140 | 24,132 | 23,651 | 23,428 | 23,399 | 23,570 | 23,470 | 25,042 | 25,112 | |
Total Stockholders' Equity (Deficit) ($M)($M) | -2,173 | -2,618 | -3,161 | -3,452 | -2,596 | -3,206 | -3,460 | -2,188 | -3,418 | -2,966 | -5,064 | -3,490 | |
Operating Cash Flow ($M)($M)4 | 3,108 | 719 | 2,324 | 3,271 | 3,094 | 205 | 2,720 | 3,340 | 2,611 | -75 | 2,877 | 3,227 | |
Capital Expenditures ($M)($M) | 109 | 57 | 93 | 92 | 54 | 32 | 38 | 47 | 31 | 29 | 35 | 53 | |
Depreciation and Amortization ($M)($M) | 60 | 56 | 56 | 54 | 70 | 71 | 71 | 73 | 74 | 74 | 65 | 78 | |
Cash Dividends Paid ($M)($M) | 1,774 | 1,776 | 1,780 | 1,785 | 1,721 | 1,724 | 1,730 | 1,737 | 1,688 | 1,687 | 1,733 | 1,739 | |
Share Repurchases Cash Outflow ($M)($M) | 400 | 55 | 280 | 288 | 112 | 274 | 326 | 310 | 680 | 10 | 2,400 | 268 | |
16 chỉ số không có số liệu trong 12 quý gần nhất — .
In nghiêng là số StockData tự tính từ số đã báo cáo (rê chuột để xem công thức). Số có gạch chân chấm là số đọc từ câu chữ trong thông cáo kết quả và bản trình bày; rê chuột để xem đúng câu đó. Tick vào một dòng để thêm vào biểu đồ phía trên (tối đa 8 đường).
Phương pháp và các chỉ số bị loại
- Các dòng ở Cốt lõi lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K và 10-Q (XBRL), có liên kết tới từng hồ sơ. Số quý 4 bằng cả năm tài chính trừ chín tháng đầu (hiện bằng chữ in nghiêng).
- Primary operational keys: Domestic Shipment Volume and Retail Share (Circana/IRI) across Smokeable Products (Marlboro, Other Premium, Discount cigarettes in million sticks; Black & Mild and Other cigars in million sticks; Contract Manufactured Export Cigarettes) and Oral Tobacco Products (Copenhagen, Skoal, on! oral nicotine pouches, and Other in million cans and packs), alongside Brand Retail Pricing ($/pack and $/can), Wholesale Inventory Estimates (billion units), and LTM Cigarette Industry Volume Decomposition.
- All growth rates, retail shares, OCI margins, and LTM industry decomposition figures are directly reported by Altria. The only computed cells are period splits from cumulative figures (Q4 = full year − nine months for Segment CapEx, Segment Depreciation, and AB InBev equity income; quarterly = year-to-date − prior year-to-date for DB cash flows), marked with Q4_NOTE and YTD_NOTE.
- Equity method investees are presented in dedicated groups using both Altria's Note 4 / Note 6 disclosures and the investees' own SEC filings: Anheuser-Busch InBev SA/NV (NYSE: BUD, ~8.1% owned by Altria, volumes in thousand hectoliters and financials in $M from Form 6-K & Form 20-F) and Cronos Group Inc. (NASDAQ: CRON, ~42.6% owned by Altria, cannabis net revenues by product and country in $K from Form 10-Q & Form 10-K).
- No Consolidated − Standalone calculation: Altria Group, Inc. reports under U.S. GAAP as a holding company without standalone parent-only operational statements.
Không hiện vì thiếu các kỳ gần đây (4)
- Conflict Minerals Smelters or Refiners (SORs) in Supply Chain (Form SD) — Only 2 consecutive annual periods in recent years (262 SORs in FY2024 for USSTC promotional items vs. 37 SORs in FY2025 for NJOY e-vapor products; no Form SD filed for FY2020–FY2023 following Nu Mark discontinuation in Dec 2018).
- Diverse Suppliers Count & Percentage of Spend on Diverse Suppliers (CR Progress Report) — Only 2 non-consecutive annual points disclosed (FY2021 baseline: 280 suppliers / 8.9% spend; FY2025: 217 suppliers / 12.0% spend; < 3 consecutive periods).
- Sphera Supplier ESG Engagement Survey Participation Rate & Harm Reduction Patents Filed (CR Progress Report) — Only 2 consecutive annual points disclosed (FY2024: 48% Sphera participation & 292 patents; FY2025: 85% Sphera participation & 289 patents; < 3 consecutive periods).
- Retail Distribution Store Counts for on! (>100,000 stores) and NJOY ACE (>100,000 stores) & Adult Tobacco Consumer Population Estimates (~55M consumers, ~30M smokers, ~28M vapor/oral users) — Disclosed predominantly in bound/approximate form ('over 100,000 stores', 'more than 42 million engagements', 'more than $3.7 billion') or discontinued in 2025 following the ITC exclusion order on NJOY ACE.
Dữ liệu cập nhật 2026-11-02.
Mỗi KPI một trang riêng
Đầy đủ lịch sử, biểu đồ, nguồn và cách trích dẫn cho từng chỉ số
1. Smokeable Products — Shipment Volume, Retail Share, Pricing & Wholesale Inventory (PM USA & Middleton)
2. Oral Tobacco & Smoke-Free Products — Shipment Volume, Retail Share & Pricing (USSTC, Helix on! & NJOY)
- Total Domestic Oral Tobacco Products Shipment Volume (million cans and packs) (M)42 kỳ
- Total U.S. Oral Tobacco Category Retail Share — USSTC & Helix (Circana / IRI, %) (%)48 kỳ
- Copenhagen Average Retail Price ($/can) ($)24 kỳ
- Total U.S. Smoke-Free Product Volume (Oral + E-Vapor, million units, FY2022–FY2024) (M)3 kỳ
3. Segment Revenues Net of Excise Taxes, Adjusted OCI, Margins, MSA Settlement & FDA Fees
4. Balance Sheet Inventories, Segment CapEx & D&A, Customer Concentration, Guidance & Monthly Share Repurchases
5. ESG, Environmental Footprint, Workforce Safety & Executive Pay Ratio
6. Equity Method Investee — Anheuser-Busch InBev SA/NV (BUD, ~8.1% Owned by Altria; Self-Reported & Note 6)
7. Equity Method Investee — Cronos Group Inc. (CRON, ~42.6% Owned by Altria; Self-Reported & Note 6)
8. U.S. Tobacco & Nicotine Industry Benchmarks (BLS Monthly CPI/PPI & PMI ZYN Cans)
9. Financial & Segment Context (Postgres DB + Q3 2026 Supplement; Absolute Values Only)
Tài liệu nguồn mới nhất
Các tài liệu được trích nhiều nhất cho số liệu mới nhất của Altria
- Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000112), filed 2026-10-29 ↗
- Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000007), filed 2026-01-29 ↗
- Altria Form 10-K (0000764180-26-000017), filed 2026-02-25 ↗
- Altria Quarterly Metrics Sheet (FY2026Q3) ↗
- Altria Form 10-Q (0000764180-26-000114), filed 2026-10-29 ↗
- Altria Form 10-K, filed 2026-02-25 ↗
- Altria Form 10-Q, filed 2026-10-29 ↗
- CIK 764180 SEC Filing (pm-release-FY2025Q4) ↗
- Altria 2024 Corporate Responsibility Progress Report (revised Sep 2025) ↗
- Altria 2025 Corporate Responsibility Progress Report (filed Sep 2026) ↗
- CIK 764180 SEC Filing (bud-6K-2026-10-29-437051-d159047dex991) ↗
- CIK 764180 SEC Filing (bud-20F-2026-03-03) ↗
See a number that looks wrong?